Becker's Healthcare March 22, 2024
Paige Twenter

On March 22, the FDA granted emergency use authorization to Pemgarda, a COVID-19 preventive medication, for patients 12 and older.

Pemgarda (pemivibart) is a monoclonal antibody that targets the SARS-CoV-2 spike protein. Clinicians are authorized to administer the drug, which must be infused for at least an hour and be followed by a repeat dose every three months.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
11 drugs now in shortage
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pfizer hemophilia gene therapy arrives in US to uncertain future
Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B
Biden administration punts menthol cigarette rule indefinitely

Share This Article